Figure-snp (Figure Snp)
Sodium Nitroprusside
Product Images NDC 70700-126
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 70700-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Metabolism (Metabolism)
This text appears to be a diagram or chart depicting the metabolism of Sodium Nitroprusside. It shows the conversion of Sodium Nitroprusside through various metabolic pathways such as cytochromes, metHgb, thiosulfate, and thiocyanate. The diagram also indicates the activation and deactivation of these pathways.*
Snp-carton-2018 (Snp Carton 2018)
This is information about Nitroprusside Injection for intravenous infusion. It is available in a single dose vial and must be diluted before use, as it is a potent drug. Blood pressure needs to be monitored before and during administration. The manufacturer is listed as XIROMED Zys. There are also instructions and precautions for use listed on the package.*
Snp-vial-2018 (Snp Vial 2018)
NDC 70700-126-92 is a Single Dose Vial of Sodium Nitroprusside Injection, containing 50 mg/2 mL (25 mg/mL) intended only for Intravenous Infusion and must be protected from light. The rest of the text is not legible.*
Xiromed (Xiromed)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
